Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft

Acute rejection (AR) after kidney transplant is one of the major obstacles to obtain ideal graft survival. Reliable molecular biomarkers for AR and renal allograft loss are lacking. This study was performed to identify novel long noncoding RNAs (lncRNAs) for diagnosing AR and predicting the risk of...

Full description

Bibliographic Details
Main Authors: Zedan Zhang, Yanlin Tang, Hongkai Zhuang, Enyu Lin, Lu Xie, Xiaoqiang Feng, Jiayi Zeng, Yanjun Liu, Jiumin Liu, Yuming Yu
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2020/2415374
id doaj-1e13aea07753456885231e05ed8b2e88
record_format Article
spelling doaj-1e13aea07753456885231e05ed8b2e882020-12-07T09:08:25ZengHindawi LimitedJournal of Immunology Research2314-88612314-71562020-01-01202010.1155/2020/24153742415374Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal AllograftZedan Zhang0Yanlin Tang1Hongkai Zhuang2Enyu Lin3Lu Xie4Xiaoqiang Feng5Jiayi Zeng6Yanjun Liu7Jiumin Liu8Yuming Yu9Department of Urology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Urology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaShantou University Medical College, Shantou 515041, ChinaDepartment of Urology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Urology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Immunology, School of Basic Medical Science, Southern Medical University, Guangzhou, ChinaDepartment of Urology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Immunology, School of Basic Medical Science, Southern Medical University, Guangzhou, ChinaDepartment of Urology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Urology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaAcute rejection (AR) after kidney transplant is one of the major obstacles to obtain ideal graft survival. Reliable molecular biomarkers for AR and renal allograft loss are lacking. This study was performed to identify novel long noncoding RNAs (lncRNAs) for diagnosing AR and predicting the risk of graft loss. The several microarray datasets with AR and nonrejection specimens of renal allograft downloaded from Gene Expression Omnibus database were analyzed to screen differentially expressed lncRNAs (DElncRNAs) and mRNAs (DEmRNAs). Univariate and multivariate Cox regression analyses were used to identify optimal prognosis-related DElncRNAs for constructing a risk score model. 39 common DElncRNAs and 185 common DEmRNAs were identified to construct a lncRNA-mRNA regulatory relationship network. DElncRNAs were revealed to regulate immune cell activation and proliferation. Then, 4 optimal DElncRNAs, ATP1A1-AS1, CTD-3080P12.3, EMX2OS, and LINC00645, were selected from 17 prognostic DElncRNAs to establish the 4-lncRNA risk score model. In the training set, the high-risk patients were more inclined to graft loss than the low-risk patients. Time-dependent receiver operating characteristics analysis revealed the model had good sensitivity and specificity in prediction of 1-, 2-, and 3-year graft survival after biopsy (AUC=0.891,0.836,and 0.733, respectively). The internal testing set verified the result well. Gene set enrichment analysis which expounded NOD-like receptor, the Toll-like receptor signaling pathways, and other else playing important role in immune response was enriched by the 4 lncRNAs. Allograft-infiltrating immune cells analysis elucidated the expression of 4 lncRNAs correlated with gamma delta T cells and eosinophils, etc. Our study identified 4 novel lncRNAs as potential biomarkers for AR of renal allograft and constructed a lncRNA-based model for predicting the risk of graft loss, which would provide new insights into mechanisms of AR.http://dx.doi.org/10.1155/2020/2415374
collection DOAJ
language English
format Article
sources DOAJ
author Zedan Zhang
Yanlin Tang
Hongkai Zhuang
Enyu Lin
Lu Xie
Xiaoqiang Feng
Jiayi Zeng
Yanjun Liu
Jiumin Liu
Yuming Yu
spellingShingle Zedan Zhang
Yanlin Tang
Hongkai Zhuang
Enyu Lin
Lu Xie
Xiaoqiang Feng
Jiayi Zeng
Yanjun Liu
Jiumin Liu
Yuming Yu
Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft
Journal of Immunology Research
author_facet Zedan Zhang
Yanlin Tang
Hongkai Zhuang
Enyu Lin
Lu Xie
Xiaoqiang Feng
Jiayi Zeng
Yanjun Liu
Jiumin Liu
Yuming Yu
author_sort Zedan Zhang
title Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft
title_short Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft
title_full Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft
title_fullStr Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft
title_full_unstemmed Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft
title_sort identifying 4 novel lncrnas as potential biomarkers for acute rejection and graft loss of renal allograft
publisher Hindawi Limited
series Journal of Immunology Research
issn 2314-8861
2314-7156
publishDate 2020-01-01
description Acute rejection (AR) after kidney transplant is one of the major obstacles to obtain ideal graft survival. Reliable molecular biomarkers for AR and renal allograft loss are lacking. This study was performed to identify novel long noncoding RNAs (lncRNAs) for diagnosing AR and predicting the risk of graft loss. The several microarray datasets with AR and nonrejection specimens of renal allograft downloaded from Gene Expression Omnibus database were analyzed to screen differentially expressed lncRNAs (DElncRNAs) and mRNAs (DEmRNAs). Univariate and multivariate Cox regression analyses were used to identify optimal prognosis-related DElncRNAs for constructing a risk score model. 39 common DElncRNAs and 185 common DEmRNAs were identified to construct a lncRNA-mRNA regulatory relationship network. DElncRNAs were revealed to regulate immune cell activation and proliferation. Then, 4 optimal DElncRNAs, ATP1A1-AS1, CTD-3080P12.3, EMX2OS, and LINC00645, were selected from 17 prognostic DElncRNAs to establish the 4-lncRNA risk score model. In the training set, the high-risk patients were more inclined to graft loss than the low-risk patients. Time-dependent receiver operating characteristics analysis revealed the model had good sensitivity and specificity in prediction of 1-, 2-, and 3-year graft survival after biopsy (AUC=0.891,0.836,and 0.733, respectively). The internal testing set verified the result well. Gene set enrichment analysis which expounded NOD-like receptor, the Toll-like receptor signaling pathways, and other else playing important role in immune response was enriched by the 4 lncRNAs. Allograft-infiltrating immune cells analysis elucidated the expression of 4 lncRNAs correlated with gamma delta T cells and eosinophils, etc. Our study identified 4 novel lncRNAs as potential biomarkers for AR of renal allograft and constructed a lncRNA-based model for predicting the risk of graft loss, which would provide new insights into mechanisms of AR.
url http://dx.doi.org/10.1155/2020/2415374
work_keys_str_mv AT zedanzhang identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
AT yanlintang identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
AT hongkaizhuang identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
AT enyulin identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
AT luxie identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
AT xiaoqiangfeng identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
AT jiayizeng identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
AT yanjunliu identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
AT jiuminliu identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
AT yumingyu identifying4novellncrnasaspotentialbiomarkersforacuterejectionandgraftlossofrenalallograft
_version_ 1715013333058322432